Results 171 to 180 of about 427 (275)
Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis
Obesity, Volume 34, Issue 6, Page 1210-1229, June 2026.ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim +3 more
wiley +1 more source
[Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection]. [PDF]
Med Clin (Barc), 2020 Herrera-Lasso Regás V +2 more
europepmc +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT The high prevalence of gastrointestinal (GI) diseases and their significant impact on the quality of life require new therapeutic strategies. The development of novel therapeutic strategies should prioritize targeting the fundamental pathophysiological mechanisms underlying these diseases, including inflammation, cellular proliferation, and ...
Sayedeh Azimeh Hosseini +7 more
wiley +1 more source
Veterinary Record Open, Volume 13, Issue 1, June 2026.Abstract Background Animal cancer registry data are important for monitoring animal health, for prevention and research in veterinary medicine, and for comparative oncology. Since people and animals share the same environment and are exposed to many common risk factors, cancer patterns in animals may have a sentinel function for human health.
Claudio Trentin +10 more
wiley +1 more source
Paracetamol prescribing to small animals by veterinarians in Australia and New Zealand
Australian Veterinary Journal, Volume 104, Issue 6, Page 327-333, June 2026.Objective To describe the prescribing patterns of paracetamol by veterinarians in Australia and New Zealand. Methods An online survey was created and distributed to veterinarians in Australia and New Zealand over a 3‐month period (July–October 2024).
A Tse, W Chee, CJ Boyd, CR Sharp
wiley +1 more source
British Journal of Haematology, Volume 208, Issue 6, Page 2036-2046, June 2026.The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Eric Oksenhendler +4 more
wiley +1 more source
BJU International, Volume 137, Issue 6, Page 1000-1013, June 2026.Objective To explore the perspectives of healthcare professionals (HCPs) on what enables or hinders shared decision‐making (SDM) in everyday small renal masses (SRM) management. Subjects and Methods A systematic literature search was conducted, which informed a structured discussion guide.
Katharina Beyer +6 more
wiley +1 more source
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomy
BJU International, Volume 138, Issue S1, Page S103-S111, June 2026.Objective To develop and validate a deep learning model for interpretation of fluorescence confocal microscopy (FCM) images for intraoperative surgical margin assessment during radical prostatectomy (RP). Patients and Methods Fluorescence confocal microscopy images from the multicentre Imperial Prostate 8‐Fluorescence Confocal Microscopy for Rapid ...
Lixiang Fang +22 more
wiley +1 more source
Colorectal Disease, Volume 28, Issue 6, June 2026.Abstract Background Colorectal cancer (CRC) screening programmes in North America have effectively reduced CRC incidence. Among the nearly six million colonoscopies performed annually in the United States, 4%–11% detect large benign colorectal neoplasms, many of which can be removed endoscopically, minimizing the need for surgery. Endoscopic removal is
Sahil Sharma +9 more
wiley +1 more source
Clinical Transplantation, Volume 40, Issue 6, June 2026.ABSTRACT Background Late‐onset non‐infectious pulmonary complications (LONIPCs) following hematopoietic stem cell transplantation (HSCT) are a known indication for need of lung transplantation. This study aimed to clarify the clinical characteristics of patients with LONIPCs after HSCT who were registered for lung transplantation and reveal the risk ...
Hisao Higo +12 more
wiley +1 more source